Wanbury Share Price | Wanbury Stock Screener
WANBURY
Pharmaceuticals
Share Price NSE
₹329.30
▼
-1.35 (-0.41%)
Share Price BSE
₹329.85
▼
-0.65 (-0.20%)
As of July 23, 2026, the Wanbury share price (NSE: WANBURY) is ₹329.30 on NSE and ₹329.85 on BSE, down 0.41% from the previous close, with shares trading between ₹326.40 and ₹338.00, and a 52-week range of ₹163.34–₹344.75.
Analyse WANBURY share price data and track historical price performance.
Use the Wanbury stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Wanbury Market Cap
₹1,178.68 Cr.
WANBURY P/E Ratio (TTM)
26.99
Wanbury P/B Ratio
14.98
EPS (TTM)
₹9.32
Dividend Yield
-
Debt to Equity
3.38
WANBURY 52 Week High
₹344.75
Wanbury 52 Week Low
₹163.34
Operating Margin
15.00%
Profit Margin
8.54%
WANBURY Revenue (TTM)
₹164.00
EBITDA
₹25.00
Net Income
₹14.00
Total Assets
₹414.00
Total Equity
₹59.00
Wanbury Share Price Chart
Screen Wanbury share price with an interactive chart. Analyse WANBURY price trends and volatility across different timeframes.
Wanbury Company Profile - Fundamental Screener
Screen Wanbury company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for WANBURY shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE107F01022
Wanbury Balance Sheet Screener
Screen WANBURY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 414 | 344 | 304 | 353 | 289 | 279 | 286 | 273 | 412 | 388 |
| Current Assets | 193 | 159 | 122 | 171 | 98 | 90 | 94 | 74 | 192 | 164 |
| Fixed Assets | 201 | 167 | 167 | 167 | 167 | 164 | 172 | 178 | 186 | 180 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 180 | 101 | 16 | 16 | 90 | 111 | 134 | 109 | 163 | 251 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 59 | 28 | -33 | -23 | -156 | -144 | -209 | -185 | -153 | -162 |
| Share Capital | 33 | 33 | 33 | 33 | 25 | 25 | 24 | 24 | 23 | 20 |
| Reserves & Surplus | 21 | -11 | -66 | -56 | -181 | -168 | -233 | -208 | -177 | -221 |
Wanbury Income Statement Screener - Profit & Revenue Analysis
Screen Wanbury income statement and profit fundamentals.
Analyze WANBURY quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Wanbury share price evaluation.
| Item | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun | 2022-Mar | 2021-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 164 | 174 | 134 | 163 | 132 | 166 | 146 | 145 | 147 | 131 | 126 | 125 | 119 | 211 | 125 |
| Expenses | 139 | 142 | 120 | 141 | 120 | 121 | 124 | 127 | 133 | 119 | 119 | 118 | 120 | 122 | 116 |
| EBITDA | 25 | 32 | 15 | 22 | 12 | 45 | 22 | 18 | 14 | 12 | 7 | 6 | -1 | 90 | 9 |
| Operating Profit % | 15.00% | 17.00% | 10.00% | 12.00% | 8.00% | 13.00% | 15.00% | 12.00% | 9.00% | 10.00% | 5.00% | 5.00% | -3.00% | 10.00% | 7.00% |
| Depreciation | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 8 | 9 | 10 | 10 | 8 | 8 | 8 | 8 | 6 | 8 | 7 | 4 | 3 | 5 | 6 |
| Profit Before Tax | 14 | 19 | 1 | 8 | 1 | 34 | 10 | 7 | 5 | 1 | -3 | -1 | -7 | 82 | 0 |
| Tax | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 |
| Net Profit | 14 | 20 | 1 | 8 | 1 | 34 | 10 | 7 | 5 | 1 | -3 | -1 | -7 | 83 | 0 |
| EPS | 4.12 | 6.18 | 0.38 | 2.44 | 0.32 | 10.28 | 3.14 | 2.25 | 1.43 | 0.31 | -1.00 | -0.27 | -2.22 | 25.62 | 0.12 |
Wanbury Cash Flow Screener - Liquidity Fundamentals
Screen WANBURY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 26 | 4 | 20 | 41 | 17 | 44 | 30 | 33 | 43 | 43 |
| Investing Activities | -51 | -17 | -9 | 1 | 8 | 64 | -3 | -1 | -13 | -20 |
| Financing Activities | 26 | 15 | -32 | -29 | -17 | -108 | -27 | -33 | -27 | -28 |
| Net Cash Flow | 1 | 2 | -21 | 13 | 7 | 0 | 0 | -2 | 3 | -5 |
Wanbury Shareholding Pattern Screener
See Wanbury shareholding pattern with promoter, FII, and DII holdings.
Check Wanbury promoter holding and ownership changes for WANBURY on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 43.02% | 39.76% | 39.63% | 43.09% | 43.07% | 39.79% | 39.79% | 39.77% |
| FII Holding | 0.59% | 1.55% | 1.59% | 0.82% | 0.72% | 0.18% | 0.22% | 1.02% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 42.17% | 41.78% | 42.06% | 41.19% | 41.28% | 41.81% | 41.42% | 40.66% |
| Other Holding | 14.23% | 16.90% | 16.71% | 14.89% | 14.92% | 18.22% | 18.57% | 18.54% |
| Shareholder Count | 16,732 | 17,889 | 17,894 | 17,717 | 17,261 | 13,087 | 14,400 | 17,199 |
Wanbury Share Dividend Screener - Share Yield Analysis
Check Wanbury dividend history with payout and yield data.
View Wanbury dividend details including ex-dates and amounts for WANBURY stock.
Wanbury Stock Index Membership
See which indices include Wanbury stock.
Check WANBURY index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Wanbury Market Events Screener - Corporate Actions
Get Wanbury corporate actions including splits, bonuses, and buybacks.
Check Wanbury stock events that may affect WANBURY share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 19.19% |
| 2026-02-05 | 2026-02-05 | Quarterly Result Announcement | NA | 58.03% |
| 2026-01-05 | 2026-01-05 | Extraordinary General Meeting | NA | 0.94% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -9.05% |
| 2025-09-18 | 2025-09-18 | Annual General Meeting | NA | -12.35% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | 10.17% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 11.60% |
| 2025-02-20 | 2025-02-20 | Extraordinary General Meeting | NA | -25.74% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -12.40% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 10.56% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | 15.79% |
| 2023-09-27 | 2023-09-27 | Annual General Meeting | NA | 27.65% |
| 2023-08-21 | 2023-08-21 | Extraordinary General Meeting | NA | 3.28% |
Wanbury Competitors Screener - Peer Comparison
Screen WANBURY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 469,310 | 40.30 | 61,674 | 12.69% | 11,565 | 62.67 |
| Divis Laboratories | 195,305 | 75.03 | 10,560 | 8.73% | 2,520 | 69.61 |
| Torrent Pharmaceuticals | 189,564 | 75.44 | 13,886 | 20.34% | 2,138 | 53.08 |
| Cipla | 117,073 | 29.67 | 29,045 | 2.24% | 3,870 | 48.42 |
| Zydus Life Science | 116,049 | 22.25 | 27,658 | 17.64% | 5,026 | 59.19 |
| Lupin | 113,522 | 20.85 | 29,039 | 26.75% | 5,356 | 54.70 |
| Mankind Pharma | 106,012 | 53.09 | 14,636 | 14.85% | 1,938 | 50.34 |
| Dr Reddys Laboratories | 102,522 | 24.31 | 35,059 | 3.90% | 4,158 | 31.90 |
| Aurobindo Pharma | 90,104 | 25.44 | 33,385 | 3.21% | 3,376 | 50.49 |
| Laurus Labs | 84,261 | 92.82 | 6,868 | 22.01% | 890 | 59.60 |
Wanbury Company Announcements - News Screener
Screen WANBURY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-21 | Clarification On Price Movement | - |
| 2026-07-21 | Clarification sought from Wanbury Ltd | - |
| 2026-07-20 | Resolution Passed Through Circulation By The Board Of Directors Of The Company | - |
| 2026-07-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-09 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-07-01 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-26 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 26.06.2026 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-10 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-02 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-29 | Outcome Of The Board Meeting Held On 29.05.2026 | - |
| 2026-05-29 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 29.05.2026 | - |
| 2026-05-12 | Update on board meeting | - |
| 2026-05-05 | Board Meeting Intimation for Notice Of Board Meeting For Approving The Audited Financial Results & Statements Of The Company For The Fourth Quarter And Year Ended 31St March 2026. | - |